A gene that may help spot slower-growing gliomas
Original title: LRRC8C is a potential diagnostic and prognostic biomarker associated with immune modulation in lower-grade glioma.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was only a computer study of stored tumor data, not a treatment.
The short version
Scientists found a gene that is more active in lower-grade glioma: A tumor that starts in the glial cells. Those are the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4. The grade says how the tumor is expected to act. See the glossary tumors.
What was studied. Researchers used gene data and health records that were already collected from people. They compared lower-grade glioma: A tumor that starts in the glial cells. Those are the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4. The grade says how the tumor is expected to act. See the glossary tissue with normal tissue and looked at a gene called LRRC8C.
What they found. The gene was more active in glioma: A tumor that starts in the glial cells. Those are the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4. The grade says how the tumor is expected to act. See the glossary tissue than in normal tissue. People with higher levels of this gene tended to live less time. That link got weaker once age and a tumor marker called IDH gene change: A small change in a tumor's IDH gene. It is the first thing your team looks at when naming an adult glioma, and it can affect which treatments are offered. Your pathology report says whether your tumor has it. See the glossary were taken into account. The same pattern showed up in another group of 271 people.
What this means, and what it doesn't
What it could mean: This gene might one day help doctors spot these tumors. It may also give a hint about how a tumor could behave. For now it mostly repeats what doctors already learn from age and IDH gene change: A small change in a tumor's IDH gene. It is the first thing your team looks at when naming an adult glioma, and it can affect which treatments are offered. Your pathology report says whether your tumor has it. See the glossary testing.
What it doesn't mean: This is not a treatment and it is not a cure. No new drug was tested here. The work was done on stored data by computer, not with patients in a clinic. The authors say their findings only show links, and lab work is needed to check them. Nothing here changes care today.
Source: PubMed, September 16, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.